When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
JNJ - J&J initiates U.S. filing for expanded use of daratumumab
Johnson & Johnson
Genmab A/S (OTCPK:GMXAY-2.1%) announces that licensee Johnson & Johnson (JNJ-1.7%) unit Janssen Biotech has launched its U.S. marketing application seeking approval to use Darzalex (daratumumab), combined with Celgene's Revlimid (lenalidomide) and dexamethasone, in treatment-naive multiple myeloma (MM) patients who are not candidates for high-dose chemo and autologous stem cell transplant.
More news on: Genmab A/S ADR, Johnson & Johnson, Healthcare stocks news,